Publications by authors named "B Devaney"
Article Synopsis
- Rapidly progressive necrotising soft tissue infections (NSTIs) are serious conditions with high risks for patients, and the NICCE offers a useful way to assess treatment effectiveness.
- A study evaluated the NICCE using a cohort of 235 patients with NSTIs, focusing on their severity through the mSOFA score; those with higher scores had worse outcomes.
- The findings suggest that NICCE is better than just using mortality rates, as it identifies patients at risk for complications and could improve the design of clinical trials, especially if it incorporates patient-centered outcomes.
A proposal for a large, multi-centre, randomised controlled trial investigating the role of hyperbaric oxygen treatment (HBOT) in necrotising soft tissue infections (NSTI) has led to much discussion locally and internationally about whether participation is ethical for a centre where stakeholders already consider HBOT standard practice. This article systematically addresses the concept of clinical equipoise specific to the role of HBOT in NSTI, and presents a series of considerations to be taken into account by key stakeholders at potential participating sites.
View Article and Find Full Text PDFIntroduction: There are inconsistencies in outcome reporting for patients with necrotising soft tissue infections (NSTI). The aim of this study was to evaluate reported outcome measures in NSTI literature that could inform a core outcome set (COS) such as could be used in a study of hyperbaric oxygen in this indication.
Methods: A systematic review of all NSTI literature identified from Cochrane, Ovid MEDLINE and Scopus databases as well as grey literature sources OpenGrey and the New York Academy of Medicine databases which met inclusion criteria and were published between 2010 and 2020 was performed.
Background: The BBraun Perfusor Space™ syringe driver is already in use by ambulance services and retrieval teams but has not previously been assessed for hyperbaric chamber use.
Methods: Pump flow accuracy was tested at rates between 1 and 40 ml· h⁻¹ using three different brands of 50 ml syringe. Function of the occlusion alarms was assessed using the same syringes.